(Q58843216)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9027379%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Suramin disrupts insulin-like growth factor-II (IGF-II) mediated autocrine growth in human SH-SY5Y neuroblastoma cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9027379%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

1 reference

1 reference

Sullivan KA

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9027379%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Kim B

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9027379%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Buzdon M

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9027379%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Feldman EL

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9027379%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9027379%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9027379%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

744

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9027379%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9027379%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

199-206

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9027379%20AND%20SRC:MED&resulttype=core&format=json

Sequence of a cDNA clone encoding human preproinsulin-like growth factor II.

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Antiproliferative effects of suramin on androgen responsive tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

A structure-activity analysis of antagonism of the growth factor and angiogenic activity of basic fibroblast growth factor by suramin and related polyanions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Experimental therapy of onchocerciasis with suramin and hetrazan; results of a three-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Clinical pharmacokinetics of suramin in patients with HTLV-III/LAV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Features of apoptotic cells measured by flow cytometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Growth, morphology, and morphometry of human hypertrophic prostate cells treated with suramin in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Insulin growth factors regulate the mitotic cycle in cultured rat sympathetic neuroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Synergistic antiproliferative activity of suramin and alpha 2A-interferon against human colorectal adenocarcinoma cell lines: in vitro studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Suramin interferes with auto/paracrine insulin-like growth factor I-controlled proliferative loop on human lung cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Mannose 6-phosphate potentiates insulin-like growth factor II effects in cultured human neuroblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Pleiotropic actions of suramin on the proliferation of human breast-cancer cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Effects of suramin on cell-cycle kinetics of MCF-7 human breast cancer cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Elevation of cytosolic calcium by cholinoceptor agonists in SH-SY5Y human neuroblastoma cells: estimation of the contribution of voltage-dependent currents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Suramin induces phosphorylation of the high-affinity nerve growth factor receptor in PC12 cells and dorsal root ganglion neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Mechanism of suramin toxicity in stable myelinating dorsal root ganglion cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Single transient potassium channels in human neuroblastoma cells induced to differentiate in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Suramin: development of a population pharmacokinetic model and its use with intermittent short infusions to control plasma drug concentration in patients with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Suramin inhibits growth and transforming growth factor-beta 1 (TGF-beta 1) binding in osteosarcoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Suramin-induced polyneuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Insulin-like Growth Factor-II as a Paracrine Growth Factor in Human Neuroblastoma Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Interferon-gamma inhibits DNA synthesis and insulin-like growth factor-II expression in human neuroblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Regulation of insulin-like growth factor-IL expression and its role in autocrine growth of human neuroblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

IGF receptor function and regulation in autocrine human neuroblastoma cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Gene expression of the insulin-like growth factors and their receptors in human neuroblastoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Insulin-like growth factor I rescues SH-SY5Y human neuroblastoma cells from hyperosmotic induced programmed cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Effects of serum and insulin-like growth factors on human neuroblastoma cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

In vitro effect of suramin on lung tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

The efficacy and distribution of suramin in the treatment of the 9L gliosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Differential inhibition of various deoxyribonucleic and ribonucleic acid polymerases by suramin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Suramin blockade of insulinlike growth factor I-stimulated proliferation of human osteosarcoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Role of the insulin-like growth factors in regulating neuroendocrine function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Suramin-induced growth inhibition and insulin-like growth factor-I binding blockade in human breast carcinoma cell lines: potentially related events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Membranous neuronal and neuroglial inclusions produced by intracerebral injection of suramin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Two types of high voltage-activated calcium channels in SH-SY5Y human neuroblastoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Role of nerve growth factor in suramin neurotoxicity studied in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Suramin: an anticancer drug with a unique mechanism of action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Insulin-like growth factor I regulates c-myc and GAP-43 messenger ribonucleic acid expression in SH-SY5Y human neuroblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Effect of suramin on 125I-insulin-like growth factor-I binding to human meningiomas and on proliferation of meningioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Biphasic effects of suramin on 125I-epidermal growth factor binding to human meningiomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

Inhibition of Breast Cancer Growth by Suramin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2896%2901078-5

10.1016/S0006-8993(96)01078-5

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9027379%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference